Women in England and Wales reject ‘exciting’ drug that could stop breast cancer from spreading
Thousands of women with advanced breast cancer in England and Wales are being denied a drug that cuts the risk of the disease spreading by more than a third. Enhertu has been approved for HER2-low breast cancer patients in Scotland and Northern Ireland, but the National Institute for Health and Care Excellence (Nice) has rejected … Read more